Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is a randomised control trial and the purpose of this study is to compare ventro-cephalic to dorso-caudal translatoric glides in management of cervicogenic headache.
Participants will be recruited into their respective groups using a coin toss method.Cervicogenic headache will be assesed using International Classification of Headache Disorders, 3rd edition:
A- Any headache fulling criterion C. B- Clinical and/or imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache.
C- Evidence of cause of headache demonstrated by at least 2 of these:
CEH subject selection is based on clinical criteria, however anaesthetic blockades is not used as a criterion.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A | Experimental | Participants of group A will receive ventro-cephalic translatoric glide, total of 3 sets with 15 repetitions per set. Duration (5 treatment sessions per week for 2 weeks) |
|
| Group B | Experimental | Participants of group B will receive Dorso-caudal translatoric glide, total of 3 sets with 15 repetitions per set. Duration (5 treatment sessions per week for 2 weeks) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ventro-Cephalic Translatoric Glide | Procedure | Participants of group A will receive ventro-cephalic translatoric glides, total of 3 sets with 15 repetitions per set. PROCEDURE:
|
| Measure | Description | Time Frame |
|---|---|---|
| Headache intensity | It will be measured on a numeric pain rating scale where participant select number ranging from 0 to 10 based on pain intensity, with 0 representing no pain and 10 denotes extreme pain. | Variable will be evaluated at baseline and then weekly for next 2 weeks. |
| Headache disability | It will be measured using headache disability index (HDI) which is a 25 item self-rated questionnaire in which participants rate their headache disability by selecting an option from 1 to 3 (yes= 4 points, sometimes= 2 points, and No = 0 point) then sum of responses is used to get final score. Interpretation: 10 to 28= mild disability 30 to 48= moderate disability 50 to 68= severe disability 72 or more= complete disability | Variable will be evaluated at baseline and then weekly for next 2 weeks |
| Quality of Life of patient | It will be measured using headache impact test (HIT-6), this tool is used to measure impact of headache on ability to function, a 6 items self-rated questionnaire in which participant select an option from 1 to 5 (Never= 6 points, rarely= 8, sometimes= 10, very often= 11, always= 13) then sum of responses is used to get final score. Interpretation: 60 or more= Very severe impact 56 to 59= Substantial impact 50 to 55= Some impact 49 or less= Little or no impact | Variable will be evaluated at baseline and then weekly for next 2 weeks |
| Headache Frequency | It will be measured using medical diary, which is a self-reported measure in which the patient will be asked to report the number of headache days per week through a medical logbook, which will be recorded every day and night. | Variable will be evaluated at baseline and then weekly for next 2 weeks |
| Cervical range of motion | It will be measured using CROM instrument a plastic frame device that is fastened to the head with help of Velcro-strap, it consist of 3 separate inclinometers that are fixed to frame (1 in sagittal plan which evaluates range of motion in flexion and extension, where 2nd in frontal plane which evaluates range of motion in side bending, and 3rd in horizontal plan which indicates range of motion in rotation) |
Not provided
Not provided
Inclusion Criteria:
• Age 18 to 44 years old
C- Evidence of cause of headache demonstrated by at least 2 of these:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Aeysha Bibi, DPT | Contact | +923058766593 | ayeshaaltaf604@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Foundation University College of Physical Therapy | Recruiting | Islamabad | 44000 | Pakistan |
Not provided
| ID | Term |
|---|---|
| D051298 | Post-Traumatic Headache |
| ID | Term |
|---|---|
| D051271 | Headache Disorders, Secondary |
| D020773 | Headache Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Randomized Control Trial
Not provided
Not provided
Not provided
Not provided
|
| Dorso-Caudal Translatoric Glide | Procedure | Participants of group B will receive Dorso-caudal translatoric glides, total of 3 sets with 15 repetitions per set. PROCEDURE:
|
|
| Variable will be evaluated at baseline and then weekly for next 2 weeks |
| Cervical flexion rotation test | It is used to evaluate impairment of cervical function as the diagnostic criterion of internation headache society (IHS) consist of subjective feathers which includes impairments at atlanto-axial motion segments which is assessed by cervical flexion rotation test. | Variable will be evaluated at baseline and then weekly for next 2 weeks |
| D009422 | Nervous System Diseases |